Saregama India Intrinsic Value
Saregama India intrinsic value. Saregama India (SAREGAMA) median intrinsic value is ₹556.70 from 10 valuation models (range ₹149–₹994), vs current price ₹497.10 — +12.0% upside (Trading Below Median Value), margin of safety 10.7%. Compare with SAREGAMA DCF valuation to assess whether the stock is under or overvalued.
SAREGAMA Valuation Methods Summary — DCF, Graham Number & P/E
Saregama India intrinsic value across 10 models vs current price ₹497.10 — upside/downside and value range per method. Read SAREGAMA ex-dividend dates for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹231.60 | ₹185.28 - ₹277.92 | -53.4% | EPS: ₹15.44, Sector P/E: 15x |
| Book Value Method | asset | ₹892.11 | ₹802.90 - ₹981.32 | +79.5% | Book Value/Share: ₹892.11, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹625.26 | ₹562.73 - ₹687.79 | +25.8% | Revenue/Share: ₹625.26, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹994.20 | ₹894.78 - ₹1093.62 | +100.0% | EBITDA: ₹516.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹426.72 | ₹341.38 - ₹512.06 | -14.2% | CF Growth: 1.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹149.13 | ₹134.22 - ₹164.04 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹159.03 | ₹143.13 - ₹174.93 | -68.0% | Revenue Growth: 6.0%, Adj P/E: 10.3x |
| ROE Based Valuation | profitability | ₹994.20 | ₹894.78 - ₹1093.62 | +100.0% | ROE: 17.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹556.70 | ₹501.03 - ₹612.37 | +12.0% | EPS: ₹15.44, BVPS: ₹892.11 |
| Dividend Yield Method | dividend | ₹150.00 | ₹135.00 - ₹165.00 | -69.8% | DPS: ₹4.50, Target Yield: 3.0% |
SAREGAMA Intrinsic Value vs Market Price — All Valuation Models
Saregama India fair value range ₹149–₹994 vs current market price ₹497.10 across 10 valuation models. For current market price and key ratios, visit Saregama India stock price NSE.
SAREGAMA Intrinsic Value Analysis — Undervalued or Overvalued?
Saregama India median intrinsic value ₹556.70, current price ₹497.10 — Trading Below Median Value by 12.0%, margin of safety 10.7%.
What is the intrinsic value of SAREGAMA?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Saregama India (SAREGAMA) is ₹556.70 (median value). With the current market price of ₹497.10, this represents a +12.0% variance from our estimated fair value.
The valuation range spans from ₹149.13 to ₹994.20, indicating ₹149.13 - ₹994.20.
Is SAREGAMA undervalued or overvalued?
Based on our multi-method analysis, Saregama India (SAREGAMA) appears to be trading below median value by approximately 12.0%.
SAREGAMA Financial Health — Key Ratios vs Industry Benchmarks
Saregama India financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 42.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.51x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SAREGAMA Cash Flow Quality — Operating & Free Cash Flow
Saregama India operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹100 Cr | ₹45 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹331 Cr | ₹221 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹93 Cr | ₹93 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹93 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹94 Cr | ₹-221 Cr | Positive Operating Cash Flow | 6/10 |